WAUKESHA, Wis. — September 22, 2014 — GE Healthcare today announced U.S. FDA 510(k) clearance of its Discovery* IQ PET/CT system, enabling both outstanding image quality and intelligent quantitation to help physicians deliver the best possible patient outcomes. Physicians not only want the ability to detect smaller lesions, but also the ability to determine whether […]
ABERDEEN, Scotland and SINGAPORE, 22 September 2014 – TauRx Therapeutics Ltd has achieved its target enrolment of 700 subjects with mild Alzheimer’s disease into the second of its two Phase III clinical trials of LMTX™, a tau aggregation inhibitor, for the treatment of Alzheimer’s disease. This multi-centre, placebo-controlled clinical trial (Protocol TRx-237-005) is aimed at […]
The new Elecsys anti-Müllerian Hormone (AMH) fertility test increases the accuracy of ovarian reserve assessment compared to conventional methods Basel, 18 September 2014 – Roche today announced the launch of the Elecsys Anti-Müllerian Hormone (AMH) blood test, the first fully-automated AMH test for assessing a woman’s ovarian reserve. AMH is an important fertility marker used […]
Presentations will include Results from the Phase III coBRIM study of Roche’s investigational MEK inhibitor cobimetinib plus Zelboraf compared to Zelboraf alone, potentially paving the way for a new standard of care Final survival data from the Phase III CLEOPATRA study of the combination of Perjeta, Herceptin and chemotherapy, further confirming the potential of this […]
GE Launches new Voluson E10 featuring world’s first curved electronic 4D probe and next generation of HDlive Barcelona, Spain September 15, 2014 – GE Healthcare announced today commercial availability in the U.S, Europe and Japan for its new Voluson E10 ultrasound system featuring the world’s first curved matrix electronic 4D probe designed specifically for OB/GYN […]
Multidisciplinary solutions to help integrate planning and improve quantitation and efficiency in radiation oncology SAN FRANCISCO, CALIFORNIA — September 15, 2014 — GE Healthcare, a division of General Electric Company (NYSE: GE), is highlighting advanced imaging technologies and software capabilities at the 56th Annual American Society for Radiation Oncology (ASTRO) Meeting in San Francisco, California. […]
Providing hospitals with important data to identify areas of improvement in the cath lab Washington, D.C. — September 14, 2014 — GE Healthcare has installed Cath Lab Efficiency Manager at Saint Luke’s Mid America Heart Institute in Kansas City, MO , a new analytical tool that analyzes the performance of an interventional lab providing hospitals […]
September 11, 2014 (St. John’s, NL): The Newfoundland and Labrador Centre for Health Information (the Centre) has partnered with GE Healthcare to install a province-wide Telepathology Network. The $2.5 million Telepathology Network, jointly funded by the Government of Newfoundland and Labrador and Canada Health Infoway, will give patients and pathologists across the province greater access […]
Crawford to move forward to pursue new roles following 31 years with Walgreens, while continuing service to company as senior counselor to President and CEO Greg Wasson Crawford to join University of Southern California School of Pharmacy as Executive in Residence and Senior Advisor to the Dean, while continuing to serve on its board of […]
Walgreens extends campaign to become year-round initiative, with goal to donate value of 6 million vaccines through Foundation’s Shot@Life campaign DEERFIELD, Ill., September 09, 2014 – Walgreens (NYSE: WAG) (Nasdaq: WAG) and the United Nations Foundation today announced the launch of the “Get a Shot. Give a Shot®” campaign, a second year collaboration to provide […]